| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/03/2005 | US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/03/2005 | US6888001 Selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimer's disease, memory loss or dementia or loss of motor function. |
| 05/03/2005 | US6887998 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 05/03/2005 | US6887889 Aryl and biaryl piperdines with MCH modulatory activity |
| 05/03/2005 | US6887875 2,5-diarypyrimidine compounds |
| 05/03/2005 | US6887874 For producing an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal; therapy of cancer, rheumatoid arthritis |
| 05/03/2005 | US6887873 Nitrogen heteroaromatic ring connected with the same or another aromatic ring through a triazine distribution agent; anticancer agents |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887864 Anticancer agents, a benzoylamino-azepan-3-yl-isonicotinamide compounds |
| 05/03/2005 | CA2347950C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 05/03/2005 | CA2309558C Substituted oximes as neurokinin antagonists |
| 05/03/2005 | CA2208704C 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
| 05/03/2005 | CA2193994C Process for synthesis of substituted sulphoxides |
| 05/03/2005 | CA2184598C Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine |
| 04/28/2005 | WO2005037834A1 NOVEL TETRAYDROSPIRO{PIPERIDINE-2,7’ -PYRROLO[3,2-b]PYRIDINE DERIVATIVES AND NOVEL INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF 5-HT6 RECEPTOR -RELATED DISORDERS |
| 04/28/2005 | WO2005037832A2 Azabicycyclic compounds for relieving pain and treating central nervous system disorders |
| 04/28/2005 | WO2005037826A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | WO2005037801A1 Pyrimidine compound |
| 04/28/2005 | WO2005037797A1 Substituted pyrazole urea compounds for the treatment of inflammation |
| 04/28/2005 | WO2005037793A1 Cyclopentene compounds |
| 04/28/2005 | WO2005037792A1 Derivatives of n-``phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics |
| 04/28/2005 | WO2005037791A1 Compositions and methods for viral inhibition |
| 04/28/2005 | WO2005037786A1 Heterocyclyl compounds |
| 04/28/2005 | WO2005037781A2 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/28/2005 | WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037285A1 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer |
| 04/28/2005 | WO2005037273A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/28/2005 | WO2005037271A2 Large conductance calcium-activated k channel opener |
| 04/28/2005 | WO2005037269A1 Novel piperidine derivative |
| 04/28/2005 | WO2005037199A2 Pyrazole derivatives as cannabinoid receptor modulators |
| 04/28/2005 | WO2005021495A3 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones |
| 04/28/2005 | WO2005019168A3 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors |
| 04/28/2005 | WO2005019163A3 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 04/28/2005 | WO2005011581A3 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 04/28/2005 | WO2005000232A3 Six membered amino-amide derivatives as angiogenesis inhibitors |
| 04/28/2005 | WO2004110351A3 Heterocyclic compounds for treating hepatitis c virus |
| 04/28/2005 | WO2004106299A3 Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 04/28/2005 | WO2004093817A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/28/2005 | WO2004089303A3 Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 04/28/2005 | WO2004089293A3 Hydroxamic acid compounds and methods of use thereof |
| 04/28/2005 | WO2004065539A3 Androgen receptor antagonists |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | WO2004005262A8 New neuropeptide y y5 receptor antagonists |
| 04/28/2005 | US20050090671 for human telomeres/telomerases; drug screening |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090667 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 04/28/2005 | US20050090541 Indolinone derivatives and their use in treating disease-states such as cancer |
| 04/28/2005 | US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide |
| 04/28/2005 | US20050090532 Medicinal uses of dihydropyrazoles |
| 04/28/2005 | US20050090529 5-pyridin-3-yl-substituted, e.g., 5-(5-ethylaminomethyl-4-methylpyridin-3-yl)-3-(1H-imidazol-2-yl)-1H-indazole; CDK mediators, used to treat cancer, as well as proliferative diseases such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis |
| 04/28/2005 | US20050090525 carboxymethylated N-(nitrogen group functionalized alkyl- carbonylhydrazido)- or carbonylaminomethylcarbonyl)- substituted; integrin inhibitors used for combating thromboses, cardiac infarction, coronary heart diseases, arteriosclerosis, inflammation, tumors, osteoporosis, infections and restenosis |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090523 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, or Alzheimer's disease; 2-[4-[3-(Piperidino)propylamino]phenyl]-8-methylimidazo[1,2-a]pyridine for example |
| 04/28/2005 | US20050090519 1-Alkyl-4-(3-substitutedphenyl)piperidines |
| 04/28/2005 | US20050090515 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors |
| 04/28/2005 | US20050090504 Crohn's disease, ulcerative colitis, asthma, hypersensitivity pneumonitis, eosinophilic pneumonias, rhinitis, psoriasis, dermatitis and eczema |
| 04/28/2005 | US20050090503 5-HT receptor ligands and uses thereof |
| 04/28/2005 | US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative |
| 04/28/2005 | US20050090497 Novel ester or amide derivatives |
| 04/28/2005 | US20050090495 Receptor binding assay using radiolabeled interleukin inhibitors; antiinflammatory agents for eosinophil-dependent inflammatory diseases |
| 04/28/2005 | US20050090494 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 04/28/2005 | US20050090490 3-Substituted-4-pyrimidone derivatives |
| 04/28/2005 | US20050090488 Drug combination for the treatment of depression and related disorders comprising mirtazapine |
| 04/28/2005 | US20050090486 Trisubstituted pyrimidines |
| 04/28/2005 | US20050090485 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders |
| 04/28/2005 | US20050090472 Xanthine oxidase inhibitors |
| 04/28/2005 | US20050090398 Aryl ketone derivatives containing tetrazole moieties such as 5-cyclopropyl-4-{2,4-dichloro-3-[(1H-tetrazol-1-yl)methyl]benzoyl}isoxazole; good effect as a selective herbicide for paddy rice |
| 04/28/2005 | US20050090381 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 04/28/2005 | CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542653A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/28/2005 | CA2542373A1 Derivatives of n-phenyl(piperidine-2-yl)methyl benzamide, preparation method thereof and applications of same in therapeutics |
| 04/28/2005 | CA2542370A1 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/28/2005 | CA2542329A1 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer |
| 04/28/2005 | CA2541509A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | CA2540861A1 Novel tetraydrospiro{piperidine-2,7' -pyrrolo[3,2-b]pyridine derivatives and novel indole derivatives useful in the treatment of 5-ht6 receptor -related disorders |
| 04/28/2005 | CA2539811A1 Azabicycyclic compounds for relieving pain and treating central nervous system disorders |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/27/2005 | EP1526131A1 Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors |
| 04/27/2005 | EP1525884A1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 04/27/2005 | EP1525882A1 Administration form comprising an acid-labile active compound |
| 04/27/2005 | EP1525197A1 Method for producing highly pure hydroxy indolyl glyoxylic acid amides |
| 04/27/2005 | EP1525196A1 Pyridyl-triazine derivatives as microbicidal active substances |
| 04/27/2005 | EP1525190A1 Cck-1 receptor modulators |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1261327B1 Adenosine receptor modulators |
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |
| 04/27/2005 | EP1034173B1 Method for producing 8-methoxy-quinoline carboxylic acids |
| 04/27/2005 | EP0931077B1 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase |
| 04/27/2005 | EP0906307B1 Substituted imidazoles having cytokine inhibitory activity |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610678A Pyrrolidone carboxamides |
| 04/27/2005 | CN1610677A Halogenated nitrobutadienes for controlling animal pests |
| 04/27/2005 | CN1610676A Compounds and method for the treatment of overactive bladder |
| 04/27/2005 | CN1610673A Method for producing pyrazole compound |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610670A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/27/2005 | CN1610669A Heteroaryl-substituted aminocyclohexane derivatives |